DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Hydroxyurea
Hydroxycarbamide
Hydroxycarbamide or hydroxyurea (brand names include Hydrea and Droxia) is an antineoplastic drug, first synthesized in 1869, used in myeloproliferative disorders, specifically polycythemia vera and essential thrombocythemia. It is also used to reduce the rate of painful attacks in sickle-cell disease and has antiretroviral properties in diseases such as AIDS.
Hydroxyurea - List of case studies
- Glioblastoma
-
HS, Reardon DA. Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol. 2007 ... , Gleevec, hydrea , imatinib mesylate , hydroxyurea . Treatments : resection of tumor , ...
- Drugs
-
acid injections Hydrea Hydrochlorthiazide Hydroxyurea Hyperthermia Hyperthermic limb perfusions ...
- Anaplastic Astrocytoma in the left temporal lobe
-
HS, Reardon DA. Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol. 2007 ... mTOR inhibitors, Gleevec, hydrea, imatinib mesylate, hydroxyurea. Treatments : stereotactic surgery, glycemic ...
- Psychomotor retardation due to spinal amyotrophy
-
acid Swoboda K et al. PloS One (2009) 4(5):1-9 . Hydroxyurea Laing W et al. Journal of the Neurological Sciences 268 (2008) ... IGF1, carnitine, valproic acid, hydroxyurea, salbutamol, steroids, protein hydrolysate ...